BioSpace News Archive

Chip Draper to serve as Senior Vice President of Worldwide Sales & Marketing leading global commercial initiatives

Educational Event Featured Presentations from Five MRIdian® Users Highlighting MR Image-guided Radiation Therapy Clinical Experience and Best Practices

Upfront payment of EUR 100 million plus up to EUR 805 million in development, regulatory and sales milestones; Foliglurax – a first-in-class development candidate for Parkinson’s disease in Phase II clinical development; Prexton sale marks third successful exit from Forbion’s most recent fund, Forbion III

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that the ReShape vBloc™ product will be discussed during the Bariatric Metabolic Surgery Standardization World Consensus Meeting taking place in New Delhi, India from March 22-24, 2018.

First and only subcutaneous immunoglobulin (SCIg) approved for the treatment of CIDP based on the largest controlled clinical study in CIDP

Tetra Bio-Pharma Inc. Announces a Non-Brokered Private Placement

Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has partnered with Exosome Diagnostics, a privately held company focused on developing and commercializing revolutionary biofluid-based diagnostics, to design and validate an assay for use in Intezyne’s upcoming Phase 1/2 clinical trials of IT-139

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that Mr. Eric Curtis, Advisor to the Chairman and CEO, will present at the 28th Annual Oppenheimer Healthcare Conference on Wednesday, March 21, 2018 at 3:55 P.M. Eastern Daylight Time at the Westin New York Grand Central in New York, New York.

Combining germline and somatic information provides more comprehensive view from diagnosis through treatment.

Dr. James Chen, the Chief Executive Officer of Origin Agritech Limited (NASDAQ: SEED) (“the Company” or “Origin”), an agricultural biotechnology trait and corn seed technology provider, presented the Company’s strategy for SEED+ Rural E-Commerce with Blockchain Technologies